Melanie H. Kucherlapati, et.al., An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents., Gastroenterology, 2010, 138

http://rdf.ncbi.nlm.nih.gov/pubmed/19931261

Melanie H. Kucherlapati, et.al., An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents., Gastroenterology, 2010, 138

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Msh2<tm3.1Rak>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4460264
• Msh2<tm2.2Rak>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4460263
• Msh2<tm2.1Rak>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4460262

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• abnormal mismatch repair_Msh2<tm2.1Rak>/Msh2<tm2.1Rak>,Tg(Vil-cre)20Syr/0
  http://metadb.riken.jp/0009797I129SvC57BL6FVBNSJLMsh2tm21RakMsh2tm21RakTgVilcre20Syr0Msh2tm21RakTgVilcre20Syr
• abnormal mismatch repair_Msh2<tm1Rak>/Msh2<tm2.1Rak>,Tg(Vil-cre)20Syr/0
  http://metadb.riken.jp/0009797I129Sv129P2OlaHsdC57BL6DBA2SJLMsh2tm1RakMsh2tm21RakTgVilcre20Syr0Msh2tm21RakTgVilcre20SyrMsh2tm1Rak
• increased intestinal adenoma incidence_Msh2<tm2.1Rak>/Msh2<tm2.1Rak>,Tg(Vil-cre)20Syr/0
  http://metadb.riken.jp/0002404I129SvC57BL6FVBNSJLMsh2tm21RakMsh2tm21RakTgVilcre20Syr0Msh2tm21RakTgVilcre20Syr
• increased small intestine adenocarcinoma incidence_Msh2<tm2.1Rak>/Msh2<tm2.1Rak>,Tg(Vil-cre)20Syr/0
  http://metadb.riken.jp/0009309I129SvC57BL6FVBNSJLMsh2tm21RakMsh2tm21RakTgVilcre20Syr0Msh2tm21RakTgVilcre20Syr
• increased intestinal adenocarcinoma incidence_Msh2<tm1Rak>/Msh2<tm2.1Rak>,Tg(Vil-cre)20Syr/0
  http://metadb.riken.jp/0002957I129Sv129P2OlaHsdC57BL6DBA2SJLMsh2tm1RakMsh2tm21RakTgVilcre20Syr0Msh2tm21RakTgVilcre20SyrMsh2tm1Rak
• abnormal tumor morphology_Msh2<tm1Rak>/Msh2<tm2.1Rak>,Tg(Vil-cre)20Syr/0
  http://metadb.riken.jp/0003448I129Sv129P2OlaHsdC57BL6DBA2SJLMsh2tm1RakMsh2tm21RakTgVilcre20Syr0Msh2tm21RakTgVilcre20SyrMsh2tm1Rak
• increased lymphoma incidence_Msh2<tm2.2Rak>/Msh2<tm2.2Rak>
  http://metadb.riken.jp/0012431I129SvC57BL6FVBNSJLMsh2tm22RakMsh2tm22RakMsh2tm22Rak
• abnormal physiological response to xenobiotic_Msh2<tm1Rak>/Msh2<tm2.1Rak>,Tg(Vil-cre)20Syr/0
  http://metadb.riken.jp/0008872I129Sv129P2OlaHsdC57BL6DBA2SJLMsh2tm1RakMsh2tm21RakTgVilcre20Syr0Msh2tm21RakTgVilcre20SyrMsh2tm1Rak
• increased intestinal adenoma incidence_Msh2<tm2.1Rak>/Msh2<tm3.1Rak>,Tg(Vil-cre)20Syr/0
  http://metadb.riken.jp/0002404I129SvC57BL6DBA2SJLMsh2tm21RakMsh2tm31RakTgVilcre20Syr0Msh2tm21RakTgVilcre20SyrMsh2tm31Rak
• increased gastrointestinal tumor incidence_Msh2<tm2.1Rak>/Msh2<tm3.1Rak>,Tg(Vil-cre)20Syr/0
  http://metadb.riken.jp/0010279I129SvC57BL6DBA2SJLMsh2tm21RakMsh2tm31RakTgVilcre20Syr0Msh2tm21RakTgVilcre20SyrMsh2tm31Rak
• increased intestinal adenoma incidence_Msh2<tm1Rak>/Msh2<tm2.1Rak>,Tg(Vil-cre)20Syr/0
  http://metadb.riken.jp/0002404I129Sv129P2OlaHsdC57BL6DBA2SJLMsh2tm1RakMsh2tm21RakTgVilcre20Syr0Msh2tm21RakTgVilcre20SyrMsh2tm1Rak
• abnormal physiological response to xenobiotic_Msh2<tm2.1Rak>/Msh2<tm3.1Rak>,Tg(Vil-cre)20Syr/0
  http://metadb.riken.jp/0008872I129SvC57BL6DBA2SJLMsh2tm21RakMsh2tm31RakTgVilcre20Syr0Msh2tm21RakTgVilcre20SyrMsh2tm31Rak
• premature death_Msh2<tm2.2Rak>/Msh2<tm2.2Rak>
  http://metadb.riken.jp/0002083I129SvC57BL6FVBNSJLMsh2tm22RakMsh2tm22RakMsh2tm22Rak
• abnormal mismatch repair_Msh2<tm2.2Rak>/Msh2<tm2.2Rak>
  http://metadb.riken.jp/0009797I129SvC57BL6FVBNSJLMsh2tm22RakMsh2tm22RakMsh2tm22Rak
• increased gastrointestinal tumor incidence_Msh2<tm2.2Rak>/Msh2<tm2.2Rak>
  http://metadb.riken.jp/0010279I129SvC57BL6FVBNSJLMsh2tm22RakMsh2tm22RakMsh2tm22Rak
• increased gastrointestinal tumor incidence_Msh2<tm1Rak>/Msh2<tm2.1Rak>,Tg(Vil-cre)20Syr/0
  http://metadb.riken.jp/0010279I129Sv129P2OlaHsdC57BL6DBA2SJLMsh2tm1RakMsh2tm21RakTgVilcre20Syr0Msh2tm21RakTgVilcre20SyrMsh2tm1Rak
• increased gastrointestinal tumor incidence_Msh2<tm2.1Rak>/Msh2<tm2.1Rak>,Tg(Vil-cre)20Syr/0
  http://metadb.riken.jp/0010279I129SvC57BL6FVBNSJLMsh2tm21RakMsh2tm21RakTgVilcre20Syr0Msh2tm21RakTgVilcre20Syr
• abnormal tumor morphology_Msh2<tm2.1Rak>/Msh2<tm3.1Rak>,Tg(Vil-cre)20Syr/0
  http://metadb.riken.jp/0003448I129SvC57BL6DBA2SJLMsh2tm21RakMsh2tm31RakTgVilcre20Syr0Msh2tm21RakTgVilcre20SyrMsh2tm31Rak
• increased intestinal adenocarcinoma incidence_Msh2<tm2.1Rak>/Msh2<tm3.1Rak>,Tg(Vil-cre)20Syr/0
  http://metadb.riken.jp/0002957I129SvC57BL6DBA2SJLMsh2tm21RakMsh2tm31RakTgVilcre20Syr0Msh2tm21RakTgVilcre20SyrMsh2tm31Rak
• increased lymphoma incidence_Msh2<tm2.1Rak>/Msh2<tm2.1Rak>,Tg(Vil-cre)20Syr/0
  http://metadb.riken.jp/0012431I129SvC57BL6FVBNSJLMsh2tm21RakMsh2tm21RakTgVilcre20Syr0Msh2tm21RakTgVilcre20Syr
• premature death_Msh2<tm2.1Rak>/Msh2<tm2.1Rak>,Tg(Vil-cre)20Syr/0
  http://metadb.riken.jp/0002083I129SvC57BL6FVBNSJLMsh2tm21RakMsh2tm21RakTgVilcre20Syr0Msh2tm21RakTgVilcre20Syr
• abnormal mismatch repair_Msh2<tm2.1Rak>/Msh2<tm3.1Rak>,Tg(Vil-cre)20Syr/0
  http://metadb.riken.jp/0009797I129SvC57BL6DBA2SJLMsh2tm21RakMsh2tm31RakTgVilcre20Syr0Msh2tm21RakTgVilcre20SyrMsh2tm31Rak

class

http://purl.org/net/cito/citesAsAuthority

• Msh2<tm3.1Rak>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4460264
• Msh2<tm2.2Rak>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4460263
• Msh2<tm2.1Rak>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4460262